Synagis

252,10 331,09 

Therapeutic RSV protein F-antibody from the original Synagis commercial drug targeting the RSV protein F-antigen, also referred to as Synagis antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Manufacturing Year Certificate of Analysis (CoA) PriceQuantityTotal
aliquot 1004043822912015Yes 331,09 
-
+
331,09 
spinner
aliquot 1004043824452015Yes 331,09 
-
+
331,09 
spinner
aliquot 1004043826152015Yes 331,09 
-
+
331,09 
spinner
aliquot 1004043826832016Yes 331,09 
-
+
331,09 
spinner
aliquot 1004043828352016Yes 331,09 
-
+
331,09 
spinner
dilution11000,1--Yes 252,10 
-
+
252,10 
spinner

Category: SKU: Synagis

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Palivizumab

Antigen

RSV protein F

Product Concentration [mg/mL]

1, 100

Volume per Vial [µL]

40, 100

Quantity per vial [mg]

0, 0,1, 4

Batch Number

NOT APPLICABLE, -, 382291, 382445, 382615, 382683, 382835

Manufacturing Year

-, 2015, 2016

Certificate of Analysis (CoA)

Yes, No, n.a.